S100A9 and Alzheimer disease: Among the brain pathologies, a widespread expression of S100A9 has been reported in cerebral malaria [22], cerebral ischemia [23], Alzheimer’s disease [18, 24], and traumatic brain injury [25], where it may initiate sustainable inflammatory responses and perform mediator functions controlling inflammatory responses of other cells.